News and Events

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) and Celltrion Asia Pacific Pte., Ltd. (“Celltrion”), a subsidiary of Celltrion Group Inc, have today announced their partnership to contract manufacture and commercialize a range of oral dosage form drugs (OSD) across the APAC region. The range of oral dosage form products will be manufactured at Bora’s Zhunan Site, which is one of the...

read more

Get the industry insights you care about

Join 3000+ subscribers and receive BORA resources in your inbox.

Resources by Category